EUVIMEDEUVIMED entdecken
EditorialKommentar

Outcomes that need to be assessed in clinical trials for cutaneous neurofibromas in people with neurofibromatosis type 1

British Journal of Dermatology · 2024

DOI: 10.1093/bjd/ljad515 ↗

Kurz gefasst

Editorial in der Zeitschrift British Journal of Dermatology, 2024. Hauptthemen laut MEDLINE: Neurofibromatosis 1, Neurofibroma, Connective Tissue Diseases, Skin Neoplasms.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurofibromatosis 1NeurofibromaConnective Tissue DiseasesSkin NeoplasmsHumansOutcome Assessment, Health Care

Zitieren

APA

(2024). Outcomes that need to be assessed in clinical trials for cutaneous neurofibromas in people with neurofibromatosis type 1. British Journal of Dermatology. https://doi.org/10.1093/bjd/ljad515

Vancouver

Outcomes that need to be assessed in clinical trials for cutaneous neurofibromas in people with neurofibromatosis type 1. British Journal of Dermatology. 2024. doi:10.1093/bjd/ljad515

BibTeX
@article{euvimed2024,
  title = {Outcomes that need to be assessed in clinical trials for cutaneous neurofibromas in people with neurofibromatosis type 1},
  journal = {British Journal of Dermatology},
  year = {2024},
  doi = {10.1093/bjd/ljad515}
}
Kostenlos starten →